1572573908586356739

#GamidaCell is enrolling patients in its Phase 1/2 study evaluating a cryopreserved formulation of #GDA201, an NK cell therapy candidate, as a treatment for patients with #follicularlymphoma and #diffuselargeBcelllymphoma.
Learn More: https://t.co/z9dRHRCrJp https://t.co/e2ddlGc9g8

Send us a message